Researchers with funding from Fight for Sight have demonstrated that a new drug treatment for cystic fibrosis and Duchenne muscular dystrophy can override a genetic fault that causes choroideremia – a ...

Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Choroideremia Treatment Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Treatment Type, Distribution Channel, Route of ...

Tod and Justin Purvis took a road trip across the United States Their documentary, "Driving Blind," was released this year Tod Purvis and his brother Justin knew that they were going blind. Both had ...

Choroideremia (CHM) is a rare genetic eye disease that affects the retina, which is the area at the back of the eye that processes all we see into signals that are sent to the brain via the optic ...

CRF acquired Spark Therapeutics, Inc.’s SPK-7001 CHM gene therapy assets and is analyzing long-term data to identify key clinical measures for development ...

Patient-developed platform brings clinical trials, scientific literature and AI-powered research tools together in one accessible resource for the CHM community ...

CRF awards four global grants to advance CHM research toward new clinical trial endpoints and therapeutic approaches—driving progress toward treatments. SPRINGFIELD ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON – Appropriate interprofessional referrals are crucial for patients diagnosed with choroideremia, ...

Major companies such as NightstaRx Ltd/Biogen, 4D Molecular Therapeutics, Curative Biotech, Therapeutics, Spark therapeutics/Roche, and others are developing potential drug candidates to improve the ...

Tod and Justin Purvis took a road trip across the United States Their documentary, "Driving Blind," was released this year Tod Purvis and his brother Justin knew that they were going blind. Both had ...